A Phase II Randomized Controlled Study of Miglustat in Adult and Juvenile Patients With Niemann-Pick Type C Disease

Trial Profile

A Phase II Randomized Controlled Study of Miglustat in Adult and Juvenile Patients With Niemann-Pick Type C Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2014

At a glance

  • Drugs Miglustat (Primary)
  • Indications Niemann-Pick disease type C
  • Focus Pharmacodynamics
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 04 Apr 2014 New trial record
    • 09 May 2009
    • 22 Jul 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top